UK markets closed

Addex Therapeutics Ltd (0QNV.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.1406+0.1406 (-21.90%)
At close: 09:27AM GMT
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.76
52-week change 3N/A
S&P500 52-week change 3-11.22%
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 89.59M
% held by insiders 112.08%
% held by institutions 112.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,707.44%

Management effectiveness

Return on assets (ttm)-87.86%
Return on equity (ttm)-202.67%

Income statement

Revenue (ttm)1.25M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-45.10%
Gross profit (ttm)-9.69M
EBITDA -21.51M
Net income avi to common (ttm)-21.58M
Diluted EPS (ttm)-0.5260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.42M
Total cash per share (mrq)0.2
Total debt (mrq)447.11k
Total debt/equity (mrq)5.62
Current ratio (mrq)2.83
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-16.31M
Levered free cash flow (ttm)-8.23M